Zheng et al (2016) found 41% of ACC cases to have alterations of ZNRF3, CTNNB1, APC and MEN1 resulting in modification of the Wnt/β-catenin pathway [17]. This evidence concerns the gene CTNNB1 and adrenal cortex carcinoma.